featured
Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment
JAMA Oncol 2021 Nov 23;[EPub Ahead of Print], Y Rottenberg, A Grinshpun, IZ Ben-Dov, E Oiknine Djian, DG Wolf, L KadouriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.